Skip to content
★ Sign in to follow
RI

RMI Investments S.A.R.L.

Shareholder
Related company / holding
Clearside Biomedical, Inc.Tobira Therapeutics, Inc.Evofem Biosciences, Inc.
Total declarations
8
Companies
3
▲ Purchases (4 ops.)
€24.1M
▼ Sales (0 ops.)
—

Latest filing published 07 Jun 2016 for Clearside Biomedical, Inc..

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 25 Nov 2014 · 4367 days ago · €788k
    -81.4%
    Entry US$84,150.00 · Close at T+365 US$15,637.50

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

RMI Investments S.A.R.L.: trading record in brief

RMI Investments S.A.R.L. is a declared insider at 3 companies; the most frequent names are Tobira Therapeutics, Inc., Clearside Biomedical, Inc. and Evofem Biosciences, Inc. Over a trading history stretching from 27 August 2013 to 7 June 2016, the count stands at 8 filings.

On the market, this insider has only ever bought: 4 purchases, €24.1M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2016, the count stands at 1 purchase and no sales.

The median purchase comes to €6.2M.

The latest filing, published on 7 June 2016, reports a transaction in Clearside Biomedical, Inc. The last insider purchase was made public on 7 June 2016, 3,807 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to RMI Investments S.A.R.L.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total

7 of 7 declarations